Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-11 of 11 for your search:
Drug:
ketoconazole
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Consolidation Therapy With or Without Strontium Chloride Sr 89 After Induction Chemotherapy in Patients With Androgen-Independent Prostate Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
Any age
Sponsor:
NCI
Protocol IDs:
MDA-ID-00156
, NCI-3410, 3410, NCT00024167
2.
A Phase III Trial of ZD4054 (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
D4320C00015
, NCT00626548
3.
Phase I/II Study of Calcitriol, Ketoconazole, and Hydrocortisone in Patients With Advanced or Recurrent Androgen-Independent Prostate Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RPCI-I-68905
, I 68905, NCT00536991
4.
Ketoconazole, Hydrocortisone, Dutasteride and Lapatanib (KHAD-L) in Prostate Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
08-374
, NCT00953576
5.
Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
BR01/07/05
, NCT00212095
6.
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
PK01/01/06
, NCT00697437
7.
177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
0810010067
, J591+Ketoconazole, NCT00859781
8.
Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
200916901
, UCDCC#218, NCT00895310
9.
Ketoconazole and Dexamethasone in Prostate Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CC # 09553
, NCT01036594
10.
Phase I Study of Fenretinide Lym-X-Sorb™ Oral Powder in Patients With Recurrent, Refractory, or Persistent Neuroblastoma
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
30 and under
Sponsor:
NCI
Protocol IDs:
NANT-N2004-04
, NCT00295919
11.
A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-263
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
M10-957
, NCT01021358
Select All on Page
Help with Results
